The researchers find Medicaid eligibility expansions are linked to increases in prescription fills for diabetes drugs.
Matthew Fielder examines how premiums would change in 2019 absent recent policy changes that are set to take effect.
Contracts should raise awareness of cost without hurting patients’ access to necessary care. argues Senior Fellow Bob Kocher and his colleague Peter Orszag.
Mark Hall examines the causes of instability in the individual market and identifies measures to help improve stability based off of interviews with key stakeholders in 10 states.
The goal of the Merit-Based Incentive Payment System, or MIPS, was to encourage clinicians to deliver more efficient, higher-quality care, but many observers have raised concerns that MIPS will fail.
Market stabilization is currently the most critical regulatory issue that public policy officials are facing. We present strategies for stabilizing the individual market.